These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17785820)

  • 1. Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter.
    Gibson HM; Hedgcock CJ; Aufiero BM; Wilson AJ; Hafner MS; Tsokos GC; Wong HK
    J Immunol; 2007 Sep; 179(6):3831-40. PubMed ID: 17785820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
    Shapiro VS; Mollenauer MN; Weiss A
    J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression.
    Gonsky R; Deem RL; Bream JH; Lee DH; Young HA; Targan SR
    J Immunol; 2000 Feb; 164(3):1399-407. PubMed ID: 10640755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transcriptional block in the IL-2 promoter at the -150 AP-1 site in effector CD8+ T cells.
    Finch RJ; Fields PE; Greenberg PD
    J Immunol; 2001 Jun; 166(11):6530-6. PubMed ID: 11359804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes.
    Miller RE; Fayen JD; Mohammad SF; Stein K; Kadereit S; Woods KD; Sramkoski RM; Jacobberger JW; Templeton D; Shurin SB; Laughlin MJ
    Exp Hematol; 2002 Jul; 30(7):738-44. PubMed ID: 12135671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells.
    Cron RQ; Bort SJ; Wang Y; Brunvand MW; Lewis DB
    J Immunol; 1999 Jan; 162(2):860-70. PubMed ID: 9916709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
    Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
    J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
    Engelhardt JJ; Sullivan TJ; Allison JP
    J Immunol; 2006 Jul; 177(2):1052-61. PubMed ID: 16818761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.
    Lindgren H; Axcrona K; Leanderson T
    J Immunol; 2001 Apr; 166(7):4578-85. PubMed ID: 11254715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.
    Hwang KW; Sweatt WB; Mashayekhi M; Palucki DA; Sattar H; Chuang E; Alegre ML
    J Immunol; 2004 Nov; 173(9):5415-24. PubMed ID: 15494488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.
    Homann D; Dummer W; Wolfe T; Rodrigo E; Theofilopoulos AN; Oldstone MB; von Herrath MG
    J Virol; 2006 Jan; 80(1):270-80. PubMed ID: 16352552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4.
    Teft WA; Madrenas J
    J Immunol; 2007 Sep; 179(6):3631-7. PubMed ID: 17785798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
    van der Stoep N; Quinten E; van den Elsen PJ
    J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CTLA-4 expression during T cell activation.
    Perkins D; Wang Z; Donovan C; He H; Mark D; Guan G; Wang Y; Walunas T; Bluestone J; Listman J; Finn PW
    J Immunol; 1996 Jun; 156(11):4154-9. PubMed ID: 8666782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
    Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
    J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
    Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
    J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line.
    Wong AW; Ghosh N; McKinnon KP; Reed W; Piskurich JF; Wright KL; Ting JP
    J Immunol; 2002 Sep; 169(6):3112-9. PubMed ID: 12218128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.